Trastuzumab emtansine plus non-pegylated liposomal doxorubicin in HER2-positive metastatic breast cancer (Thelma): A single-arm, multicenter, phase Ib trial

  1. López-Miranda, E.
  2. Pérez-García, J.M.
  3. Di Cosimo, S.
  4. Brain, E.
  5. Ravnik, M.
  6. Escrivá-De-romaní, S.
  7. Vidal, M.
  8. Gligorov, J.
  9. Borštnar, S.
  10. Calabuig, L.
  11. Sampayo-Cordero, M.
  12. Malfettone, A.
  13. Llombart-Cussac, A.
  14. Suter, T.M.
  15. Cortés, J.
Aldizkaria:
Cancers

ISSN: 2072-6694

Argitalpen urtea: 2020

Alea: 12

Zenbakia: 12

Orrialdeak: 1-14

Mota: Artikulua

DOI: 10.3390/CANCERS12123509 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus